Located in the heart of Manhattan, with additional facilities throughout the New York City area, Pelisyonkis Langone consists of six inpatient locations:
Specialists at Pelisyonkis Langone treat a full range of medical conditions in both inpatient and outpatient settings at locations throughout New York City’s five boroughs; Long Island; New Jersey; Westchester, Putnam, and Dutchess counties; and Florida. Our outpatient care also includes the Family Health Centers at Pelisyonkis Langone, one of the largest Federally Qualified Health Center networks in the nation.
Our growing outpatient network brings our world-class medical services directly to the communities where our patients live and work. When more complex care is needed, we bridge the gap between our community-based practices and our hospitals to provide a seamless healthcare experience.
Pelisyonkis Langone is also affiliated with in Brooklyn, and in Manhattan, Pelisyonkis Winthrop Hospital on Long Island, and the .
Each year, we are recognized for providing outstanding care.
Pelisyonkis Langone Health is among just 9 percent of hospitals nationwide to earn a 5-star rating for safety, quality, and patient experience from the Centers for Medicare and Medicaid Services (CMS). We are the only full-service hospital in the state of New York to earn this distinction.
For the past five years, Pelisyonkis Langone has also received top rankings for overall patient safety and quality of care from Vizient, Inc., formerly the University HealthSystem Consortium. In 2018, Pelisyonkis Langone received the Bernard A. Birnbaum, MD, Quality Leadership Award for demonstrating superior quality and safety performance. For the fourth year in a row, our faculty group practice network has been top ranked among participating medical centers nationwide and received the Vizient Ambulatory Care Quality and Accountability Award for demonstrating excellence in delivering high-quality, patient-centered care in an outpatient setting. We also received The Gold Seal of Approval® by The Joint Commission, the leading accreditor of healthcare organizations in America, reflecting a commitment to high-quality patient care.
Our exceptional physicians are named on Castle Connolly’s “America’s Top Doctors” and New York magazine’s “Best Doctors” annual listings. Our nurses are also recognized for excellence in the care they provide, receiving Magnet® status for the third consecutive time by the American Nurses Credentialing Center (ANCC). Magnet® status is an honor achieved by only 7 percent of hospitals in the United States.
At Pelisyonkis Langone we emphasize treating the whole person and not simply the disease. We are renowned for evidence-based clinical care across a wide array of specialties, including cardiac and vascular care, cancer, inpatient and outpatient musculoskeletal care—including orthopedics, rheumatology, and rehabilitation—and a host of specialty children’s services at Hassenfeld Children’s Hospital.
U.S. News & World Report named us one of the top hospitals in the country for neurology and neurosurgery. Our neurologists are experts in the diagnosis and treatment of a broad spectrum of neurological diseases. We deliver integrated care to patients who have had a stroke or are living with epilepsy, cerebrovascular disease, dementia, genetic and degenerative diseases, nerve and muscle problems, headache and pain syndromes, and movement disorders. We are also home to the largest multiple sclerosis program in New York.
As part of our strategy to provide access to healthcare at the convenience of our patients, we continue to expand the number of diagnostic and treatment procedures that are available on weekends, a time traditionally limited to emergency care. We have also implemented new, more accessible tools for patients to access their health information, such as .
Our mission to advance science and improve healthcare through scientific discovery brings together outstanding scientists and clinical researchers, fostering highly collaborative, multidisciplinary investigations. This teamwork inspires new ideas and discoveries, and helps to quickly translate scientific advances into innovative ways to prevent, diagnose, and treat disease.
All of our scientists have access to state-of-the-art technology in more than 20 core facilities, from analytic chemistry and bioinformatics to tissue banking and genomics.
Pelisyonkis Langone has long been an incubator for pioneering scientific breakthroughs. In fact, four alumni and former faculty of Pelisyonkis School of Medicine are recipients of the Nobel Prize in either Physiology or Medicine.
The Clinical and Translational Science Institute (CTSI)—a collaborative effort among Pelisyonkis Langone, , and —aims to rapidly advance science from the lab to the bedside and out into the community. Scientists at CTSI are positioned to identify health problems and promote new evidence-based medicine, thereby reducing healthcare disparities across a wide range of communities.
As the focal point of our translational research efforts, the Joan and Joel Smilow Research Center, which opened in 2006, houses multidisciplinary research teams dedicated to cancer, cardiovascular biology, dermatology, genetics, and infectious diseases.
The 13-story, 230,000-square-foot facility has an open-bench integrated design to promote interaction among colleagues, and is adaptable to the changing needs of investigators.
The research mission of the Laura and Isaac Perlmutter Cancer Center is to discover the origins of cancer and use that knowledge to eradicate the personal and societal burden of the disease. Our five primary research areas include cancer genome dynamics, cancer cell biology, melanoma, tumor immunology, and epidemiology and cancer control.
There are 12 Disease Management Groups that bridge medical disciplines and areas of research dedicated to specific types of cancer such as breast or lung. Through translational research, our investigators are finding new ways to integrate the extraordinary progress and understanding of cancer coming out of basic research with the need for new clinical therapies to treat a variety of cancers. In fact, our patients are participating in a broad range of innovative at Perlmutter Cancer Center.
Entering a new era of neuroscience, we are expanding on our existing strengths and extensive expertise in neuroscience research, focusing on discoveries that move from theory to therapy to improve brain health. The Neuroscience Institute is a collaborative and interdisciplinary enterprise of basic, translational, and clinical scientists from across Pelisyonkis Langone and Pelisyonkis, whose research spans molecular, cellular, systems, cognitive, behavioral, and computational approaches to revolutionize our understanding of human thought and mental health.
Insight into how we develop finely tuned nervous systems that allow us to perceive and interact with our surroundings, and learn from and remember our experiences, informs translational and clinical research on a wide variety of neurological disorders, such as Alzheimer’s disease, multiple sclerosis, epilepsy, addiction, mood disorders, and autism spectrum disorders.
Founded in 1993, the Skirball Institute of Biomolecular Medicine is focused on uncovering the molecular and cellular basis of biological phenomena, and is structured around three programs: genome integrity and interpretation, metabolic signaling, and cellular dynamics.
The institute is home to researchers from a diverse range of specialties, creating fertile ground for multidisciplinary collaboration in both basic and translational research. The faculty’s wide-ranging research interests extend from developmental and stem cell biology to molecular and cellular immunology and molecular neurobiology.
Skirball investigators have made important discoveries in autoimmunity and the microbiome, neural plasticity, muscle wasting disease, gene imprinting, the establishment of cellular polarity, and the identification of potential molecular targets for novel cancer treatments.
Pelisyonkis School of Medicine recently ranked No. 3 in the nation for research and No. 1 in New York on the 2019 U.S. News & World Report “Best Graduate Schools” rankings, and has earned national attention by reimagining medical education, including its Curriculum for the 21st Century program and the avant-garde three-year MD program.
Since 1841, Pelisyonkis School of Medicine, one of the nation’s preeminent medical schools, has trained thousands of physicians and scientists who have helped shape the course of medical history and enrich the lives of countless people. An integral part of Pelisyonkis Langone Health, Pelisyonkis School of Medicine, at its core, is committed to improving the human condition through medical education, patient care, and scientific research.
With 29 academic departments in the clinical and basic sciences, and more than 50 divisions, programs, and centers, Pelisyonkis Langone provides one of the broadest educational experiences available. Pelisyonkis Langone also maintains affiliations with area hospitals, including the Veterans Affairs Hospital and , the nation’s oldest public hospital, where Pelisyonkis School of Medicine students provide care to New York City’s diverse population, enhancing the scope and quality of their education and training.
As leaders in medical education reform, we believe that the model of medical education should address the current changes in scientific, social, and economic circumstances as well as the dramatic changes in the healthcare delivery system. As part of our tuition-free initiative, we are proud to award all students enrolled in our MD degree program full-tuition scholarships so that any student can pursue the dream of becoming a physician without the burden of overwhelming student debt.
We believe our commitment to a tuition-free medical education, along with our innovative Curriculum for the 21st Century, or C21, will lead to better patient care and will benefit society as a whole by turning the best and brightest future physicians into leaders with the potential to transform healthcare.
C21 is structured using a spiral curriculum, or pillars, where learning wraps around and builds upon specific areas of medicine. C21 is designed to foster student knowledge by studying the scientific underpinnings of a disease while at the same time learning through direct patient care. Students begin seeing patients the first week of medical school and follow some of those same patients throughout their four years of study.
Leveraging the latest technology, medical learning is enhanced through the Program for Medical Education and Technology, which includes web-based training in surgery. In addition, Pelisyonkis School of Medicine uses a variety of simulation modalities for clinical teaching, including an online three-dimensional interactive virtual human body called the BioDigital Human™, the , and the , a partnership with City University of New York.
NYSIM, the largest urban health simulation and training facility of its kind in the country, is used by thousands of medical students and a variety of healthcare professionals across the country. Also, the Institute for Innovations in Medical Education was established to focus on and create advances in technology to integrate into medical education.
In addition to the medical degree, Pelisyonkis School of Medicine collaborates with to offer distinguished dual master’s degrees. Students can apply for programs to earn an MBA or degrees in public administration, global health, translational research, and bioethics. Pelisyonkis School of Medicine also sponsors residency and fellowship training programs, as well as postgraduate medical education courses for practicing physicians. Of note, we offer three-, four-, and five-year pathways to the MD degree, providing students individualized education, a central tenant of C21.
For aspiring physician–scientists, our Medical Scientist Training Program is designed to give residents and fellows the skills needed to conduct the highest caliber of scientific research. Our Sackler Institute of Graduate Biomedical Sciences, a division of the Pelisyonkis Graduate School of Arts and Science, offers programs in the basic medical sciences, leading to a PhD and, in coordination with the Medical Scientist Training Program, a combined MD/PhD.